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The birth of ‘Dolly the sheep’ (the first animal to be 
cloned from an adult (somatic) cell) on 5th July 1996 
marked a seminal moment in the field of developmental 
genetics for several reasons. It first provided unequivocal 
evidence of genomic equivalence between embryonic 
and somatic cells by demonstrating that it is possible 
to re-establish a pluripotent state in differentiated 
cells. In so doing, it inspired others to later identify at 
least some of the factors required for the induction of 
pluripotency in cultured somatic cells leading to the 
creation of ‘induced’ pluripotent stem cells (iPSCs) for 
therapeutic applications in both human and animal 
medicine (Takahashi & Yamanaka 2006). However, it 
was the need to develop an effective method by which to 
produce genetically modified (GM) livestock that drove 
the programme of work that ultimately led to the birth 
of Dolly. Existing GM approaches at that time relied on 
techniques, such as pronuclear DNA microinjection. 
These techniques were both inefficient and limited 
in their ability to introduce genetic change in large 
animals. Furthermore, in contrast to mice (Evans & 
Kaufman 1981, Martin 1981), the derivation and 
establishment of germ-line competent embryonic-stem 
cells (so amenable for introducing genetic modification 
in that species) has thus far remained elusive in livestock 
species. Thus, the approach adopted by Wilmut et  al. 
(1997) involved the transfer of nuclei from somatic (i.e. 
cultured mammary) cells to enucleated oocytes followed 
by electrofusion and activation; a procedure referred to 
as somatic-cell nuclear transfer (SCNT).
The success of Dolly led quickly to a succession of 
papers reporting the birth of GM livestock derived from 
genetically altered somatic cells (e.g. Schnieke et  al. 
1997, Cibelli et al. 1998, Dai et al. 2002). However, both 
ethical and biological concerns regarding the underlying 
cloning procedure were raised at the time. Biological 
concerns related to the overall efficiency of SCNT, in 
utero and perinatal losses, together with the ‘biological’ 
age, longevity and health of cloned offspring; all of which 
threatened the prospect of generating GM animals by 
this means. In utero losses, developmental abnormalities 
and neonatal morbidity were attributable, at least in part, 
to the culture of gametes and embryos, which contribute 
independently to epigenetic dysregulation at both 
imprinted and non-imprinted loci (Young et  al. 2001, 
Chen et  al. 2017), leading to a phenomenon known 
as the large offspring syndrome (Young et  al. 1998). 
Concerns were raised specifically about the health of 
Dolly, as she was diagnosed with osteoarthritis (OA) of 
the left stifle at a relatively young (5½ years) age (Rhind 
et al. 2004). It was suggested that she might have aged 
prematurely, and terminal fragment restriction analyses 
of her genomic DNA appeared to support the concept 
of telomere shortening (Shiels et al. 1999). However, this 
observation was at odds with those from other SCNT 
studies which generally found telomeres to ‘rejuvenate’ 
during nuclear reprogramming (Marión & Blasco 
2010). Furthermore, our own retrospective radiographic 
assessments of the skeletons of Dolly, Megan and Morag 
(the latter two sheep had been cloned previously from 
differentiated cells; Campbell et  al. 1996) reported a 
prevalence and severity of OA no different to that of 
naturally conceived sheep of comparable age (Corr 
et al. 2017). Indeed, several studies over the years have 
concluded that cloned offspring which survive beyond 
the neonatal period are healthy, age normally, produce 
viable offspring and animal products safe for human 
consumption (Lanza et  al. 2001, Yang et  al. 2007, 
Watanabe 2013, Sinclair et  al. 2016). Yet concerns 
relating to animal welfare remain, and these have been 
sufficient to enforce a ban on commercial farm-animal 
cloning within the UK and EU, although not within the 
US and many other countries.
The consequence of this ban is that, in an era of 
comparatively well-funded iPSC research, the ability 
to undertake studies to improve the overall efficiency, 
safety and application of SCNT has been impeded. Yet, 
despite the global investment in iPSC research over the 
last 20 years, its potential for cell-based therapy has yet 
to be realised (Yamanaka 2020). Other commentators 
emphasise the merits of zygotic genome editing, using 
designer nucleases such as CRISPR/Cas9, to generate GM 
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livestock, thus obviating the need for the more technically 
demanding SCNT (Tan et al. 2016). However, embryo 
mosaicism and low and variable germ-line transmission 
present challenges with this approach, particularly 
when multiplexed gene editing is required (Tanihara 
et  al. 2021). Therefore, 25 years on, this anniversary 
issue of Reproduction addresses the question: is there 
still a role for SCNT in reproductive and regenerative 
medicine? It also considers how our understanding of the 
molecular mechanisms that underlie pregnancy failure 
and neonatal loss has improved over the past 25 years, 
describing refinements to procedures that impact on the 
overall efficiency of SCNT, whilst discussing residual 
ethical and societal concerns related to use of advanced 
reproductive technologies in animals and humans.
The issue (Video 1) opens with a brief historical 
perspective of the scientific legacy of Dolly from one of 
the co-authors (Prof Dr Angelika Schnieke) of the article 
that first reported this development in 1997. Klinger 
& Schnieke (2021) summarise current applications 
of SCNT and discuss its relevance in the 21st century. 
There then follows two articles that each provide both a 
historical and contemporary perspective on the role of 
SCNT in the generation of GM livestock. The first article 
(Polejaeva 2021) provides a detailed overview of the 
technical advances made in GM technologies over the 
past 25 years from a leading member of the team that 
produced the first cloned pigs by SCNT in 2000. This 
article also offers a perspective on the current and future 
role of SCNT in the creation of genetically engineered 
animals; a perspective that is extended by Galli & 
Lazzari (2021) who consider applications in several 
large-animal species together with intellectual-property 
and regulatory challenges that will ultimately determine 
its use.
Video 1
Professor Kevin Sinclair provides a video introduction 
to this anniversary edition on cloning by somatic-
cell nuclear transfer. This video (http://movie-usa. 
glencoesoftware.com/video/10.1530/REP-21-0212/ 
video-1) is availablefrom the online version of the article 
at https://doi.org/10.1530/REP-21-0212.
The anniversary issue next considers the science 
underpinning SCNT. The establishment of a pluripotent 
state following nuclear transfer requires significant 
remodelling of inherited chromatin to occur within a 
matter of hours following reconstruction. These aspects 
are discussed for both farm and companion animals (Loi 
et al. 2021), and mice (Ogura et al. 2021), with emphasis 
placed on epigenetic modifications to chromatin 
required to induce a pluripotent state. Consideration is 
also given to the molecular events involved in chromatin 
remodelling in male and female gametes in the lead-up 
to syngamy during natural conception. It is based on the 
premise that a better understanding of these processes 
may lead to innovative approaches that will improve the 
overall efficiency of nuclear reprogramming.
The penultimate article in this series (Alberio & Wolf 
2021) returns to the topic of GM livestock, considering 
further applications in animal breeding and the 
development of large-animal models for early human 
development and disease. The prospect of generating 
embryonic stem cells in farm animals may obviate the 
need for somatic cells and improve the overall efficiency 
of GM-livestock production, superseding current zygotic 
genome-editing approaches. The transfer of nuclei from 
such cells, rather than the creation of chimeric embryos, 
could then emerge to become the most effective means 
by which to establish GM-founder stock.
Finally, reference was made earlier in this editorial 
to ethical concerns raised following the birth of Dolly 
in 1996. The concluding article in this anniversary 
edition considers these issues and proposes that many 
of the concerns raised at that time persist to this day, 
although the context has somewhat shifted towards the 
use of genetic technologies that influence inheritance in 
both humans and farm animals (Greenfield 2021). The 
point is made that scientific and political judgements of 
what might be in the public interest may not necessarily 
be what the public wants or would choose. At the 
very least, it would seem that some 25 years later, the 
debate around the safe and ethical use of advanced 
reproductive technologies in human medicine and 
livestock production is ‘…still goin’ strong’.
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